Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD
Authors
Keywords
Chronic obstructive pulmonary disease, COPD, GSK2269557, Inhaled PI3Kδ inhibitor, Pharmacokinetics, Dose-response
Journal
PULMONARY PHARMACOLOGY & THERAPEUTICS
Volume 46, Issue -, Pages 69-77
Publisher
Elsevier BV
Online
2017-08-17
DOI
10.1016/j.pupt.2017.08.008

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.